Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil in Achieving 24-Hour Blood Pressure Reductions and Ambulatory Blood Pressure Goals-Reference-Cited by-同舟云学术

Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil in Achieving 24-Hour Blood Pressure Reductions and Ambulatory Blood Pressure Goals

Published:2006 Issue:4 Volume:26 Page:185-193
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clinical Drug Investigation

Author:

Brunner Hans R,Arakawa Kikuo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Reference25 articles.

1. Selected major risk factors and global and regional burden of disease

2. Blood Pressure as a Cardiovascular Risk Factor

3. Chronotherapeutics for Cardiovascular Disease

4. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): “Issues with hypertension studies in real-world practice”;Clinical and Experimental Hypertension;2019-11-22

2. Effect of antihypertensive treatment on 24-h blood pressure variability;Journal of Hypertension;2018-04

3. A literature review to evaluate the clinical and economic value of olmesartan for the treatment of hypertensive patients;International Journal of Cardiology;2016-10

4. Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension;Journal of the American Society of Hypertension;2016-01

5. Lipid and Blood Pressure Control for the Prevention of Cardiovascular Disease in Hypertensive Patients: A Subanalysis of the OMEGA Study;Journal of Atherosclerosis and Thrombosis;2015